Global (R)-Duloxetine (CAS 116539-60-7) market was valued at USD 1.87 billion in 2025 and is projected to reach USD 3.64 billion by 2034, exhibiting a remarkable CAGR of 6.8% during the forecast period.  (R)-Duloxetine (CAS 116539-60-7) is the pharmacologically active enantiomer of duloxetine, a serotonin-norepinephrine reuptake inhibitor (SNRI) widely used in the treatment of major...

" According to the latest report published by Data Bridge Market Research, the Duloxetine Market  The global duloxetine market size was valued at USD 6.20 billion in 2024 and is expected to reach USD 8.88 billion by 2032, at a CAGR of 4.60% during the forecast period. The large scale Duloxetine Marketing report studies and evaluates market drivers, market restraints,...